Weaver Capital Management LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,578 shares of the medical equipment provider’s stock after buying an additional 249 shares during the quarter. Weaver Capital Management LLC’s holdings in Intuitive Surgical were worth $1,346,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also made changes to their positions in the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the 4th quarter valued at $82,517,000. Exome Asset Management LLC increased its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Consolidated Planning Corp increased its holdings in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in Intuitive Surgical by 73.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after purchasing an additional 114,149 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ISRG has been the subject of several recent research reports. Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.
Insider Activity
In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,843 shares of company stock valued at $15,357,560. Insiders own 0.80% of the company’s stock.
Intuitive Surgical Trading Up 0.2 %
ISRG opened at $579.65 on Wednesday. The business’s 50 day moving average is $551.24 and its 200-day moving average is $511.16. The stock has a market cap of $206.46 billion, a PE ratio of 90.43, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Health Care Stocks Explained: Why You Might Want to Invest
- Atlassian: Upside Still in Play After Impressive Earnings Spike
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Use the MarketBeat Stock Screener
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.